The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients ...
Scope Technologies Corp. ("Scope" or the "Company") is pleased to announce the signing of a Letter of Intent (the "LOI") with Global Care Innovations Inc. ("GCI") and BitLab. This strategic ...